Triamterene nephrolithiasis

Publisher Website
Google Scholar
Abstract
Triamterene was identified in 181 renal calculi (0.4% of 50,000 calculi submitted for analysis). Triamterene formed the nucleus of the stone or was deposited with calcium oxalate or uric acid. One third of these stones were mainly or entirely triamterene, though a similar proportion had only minor amounts. A recommended dose of triamterene-hydrochlorothiazide sufficed to produce triamterene deposition in renal calculi. The annual incidence of the complication is about 1 per 1500 users of triamterene-hydrochlorothiazide. Triamterene lithiasis develops particularly in persons who have had a renal stone, and they should not receive this drug.

This publication has 2 references indexed in Scilit: